Cargando…

Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat

Globally, biomonitoring data demonstrate virtually all humans carry residues of multiple per- and polyfluoroalkyl substances (PFAS). Despite pervasive co-exposure, limited mixtures-based in vivo PFAS toxicity research has been conducted. Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic aci...

Descripción completa

Detalles Bibliográficos
Autores principales: Conley, Justin M., Lambright, Christy S., Evans, Nicola, Medlock-Kakaley, Elizabeth, Dixon, Aaron, Hill, Donna, McCord, James, Strynar, Mark J., Ford, Jermaine, Gray, L. Earl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944680/
https://www.ncbi.nlm.nih.gov/pubmed/36402036
http://dx.doi.org/10.1016/j.envint.2022.107631
_version_ 1785145845874688000
author Conley, Justin M.
Lambright, Christy S.
Evans, Nicola
Medlock-Kakaley, Elizabeth
Dixon, Aaron
Hill, Donna
McCord, James
Strynar, Mark J.
Ford, Jermaine
Gray, L. Earl
author_facet Conley, Justin M.
Lambright, Christy S.
Evans, Nicola
Medlock-Kakaley, Elizabeth
Dixon, Aaron
Hill, Donna
McCord, James
Strynar, Mark J.
Ford, Jermaine
Gray, L. Earl
author_sort Conley, Justin M.
collection PubMed
description Globally, biomonitoring data demonstrate virtually all humans carry residues of multiple per- and polyfluoroalkyl substances (PFAS). Despite pervasive co-exposure, limited mixtures-based in vivo PFAS toxicity research has been conducted. Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) are commonly detected PFAS in human and environmental samples and both produce adverse effects in laboratory animal studies, including maternal and offspring effects when orally administered during pregnancy and lactation. To evaluate the effects of combined exposure to PFOA and PFOS, we orally exposed pregnant Sprague-Dawley rats from gestation day 8 (GD8) to postnatal day 2 (PND2) to PFOA (10–250 mg/kg/d) or PFOS (0.1–5 mg/kg/d) individually to characterize effects and dose response curve parameters, followed by a variable-ratio mixture experiment with a constant dose of PFOS (2 mg/kg/d) mixed with increasing doses of PFOA (3–80 mg/kg/d). The mixture study design was intended to: 1) shift the PFOA dose response curves for endpoints shared with PFOS, 2) allow comparison of dose addition (DA) and response addition (RA) model predictions, 3) conduct relative potency factor (RPF) analysis for multiple endpoints, and 4) avoid overt maternal toxicity. Maternal serum and liver concentrations of PFOA and PFOS were consistent between the individual chemical and mixture experiments. Combined exposure with PFOS significantly shifted the PFOA dose response curves towards effects at lower doses compared to PFOA-only exposure for multiple endpoints and these effects were well predicted by dose addition. For endpoints amenable to mixture model analyses, DA produced equivalent or better estimates of observed data than RA. All endpoints evaluated were accurately predicted by RPF and DA approaches except for maternal gestational weight gain, which produced less-than-additive results in the mixture. Data support the hypothesis of cumulative effects on shared endpoints from PFOA and PFOS co-exposure and dose additive approaches for predictive estimates of mixture effects.
format Online
Article
Text
id pubmed-9944680
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-99446802023-12-01 Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat Conley, Justin M. Lambright, Christy S. Evans, Nicola Medlock-Kakaley, Elizabeth Dixon, Aaron Hill, Donna McCord, James Strynar, Mark J. Ford, Jermaine Gray, L. Earl Environ Int Article Globally, biomonitoring data demonstrate virtually all humans carry residues of multiple per- and polyfluoroalkyl substances (PFAS). Despite pervasive co-exposure, limited mixtures-based in vivo PFAS toxicity research has been conducted. Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) are commonly detected PFAS in human and environmental samples and both produce adverse effects in laboratory animal studies, including maternal and offspring effects when orally administered during pregnancy and lactation. To evaluate the effects of combined exposure to PFOA and PFOS, we orally exposed pregnant Sprague-Dawley rats from gestation day 8 (GD8) to postnatal day 2 (PND2) to PFOA (10–250 mg/kg/d) or PFOS (0.1–5 mg/kg/d) individually to characterize effects and dose response curve parameters, followed by a variable-ratio mixture experiment with a constant dose of PFOS (2 mg/kg/d) mixed with increasing doses of PFOA (3–80 mg/kg/d). The mixture study design was intended to: 1) shift the PFOA dose response curves for endpoints shared with PFOS, 2) allow comparison of dose addition (DA) and response addition (RA) model predictions, 3) conduct relative potency factor (RPF) analysis for multiple endpoints, and 4) avoid overt maternal toxicity. Maternal serum and liver concentrations of PFOA and PFOS were consistent between the individual chemical and mixture experiments. Combined exposure with PFOS significantly shifted the PFOA dose response curves towards effects at lower doses compared to PFOA-only exposure for multiple endpoints and these effects were well predicted by dose addition. For endpoints amenable to mixture model analyses, DA produced equivalent or better estimates of observed data than RA. All endpoints evaluated were accurately predicted by RPF and DA approaches except for maternal gestational weight gain, which produced less-than-additive results in the mixture. Data support the hypothesis of cumulative effects on shared endpoints from PFOA and PFOS co-exposure and dose additive approaches for predictive estimates of mixture effects. 2022-12 2022-11-12 /pmc/articles/PMC9944680/ /pubmed/36402036 http://dx.doi.org/10.1016/j.envint.2022.107631 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Conley, Justin M.
Lambright, Christy S.
Evans, Nicola
Medlock-Kakaley, Elizabeth
Dixon, Aaron
Hill, Donna
McCord, James
Strynar, Mark J.
Ford, Jermaine
Gray, L. Earl
Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat
title Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat
title_full Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat
title_fullStr Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat
title_full_unstemmed Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat
title_short Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat
title_sort cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (pfoa) and perfluorooctane sulfonic acid (pfos) during pregnancy in the sprague-dawley rat
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944680/
https://www.ncbi.nlm.nih.gov/pubmed/36402036
http://dx.doi.org/10.1016/j.envint.2022.107631
work_keys_str_mv AT conleyjustinm cumulativematernalandneonataleffectsofcombinedexposuretoamixtureofperfluorooctanoicacidpfoaandperfluorooctanesulfonicacidpfosduringpregnancyinthespraguedawleyrat
AT lambrightchristys cumulativematernalandneonataleffectsofcombinedexposuretoamixtureofperfluorooctanoicacidpfoaandperfluorooctanesulfonicacidpfosduringpregnancyinthespraguedawleyrat
AT evansnicola cumulativematernalandneonataleffectsofcombinedexposuretoamixtureofperfluorooctanoicacidpfoaandperfluorooctanesulfonicacidpfosduringpregnancyinthespraguedawleyrat
AT medlockkakaleyelizabeth cumulativematernalandneonataleffectsofcombinedexposuretoamixtureofperfluorooctanoicacidpfoaandperfluorooctanesulfonicacidpfosduringpregnancyinthespraguedawleyrat
AT dixonaaron cumulativematernalandneonataleffectsofcombinedexposuretoamixtureofperfluorooctanoicacidpfoaandperfluorooctanesulfonicacidpfosduringpregnancyinthespraguedawleyrat
AT hilldonna cumulativematernalandneonataleffectsofcombinedexposuretoamixtureofperfluorooctanoicacidpfoaandperfluorooctanesulfonicacidpfosduringpregnancyinthespraguedawleyrat
AT mccordjames cumulativematernalandneonataleffectsofcombinedexposuretoamixtureofperfluorooctanoicacidpfoaandperfluorooctanesulfonicacidpfosduringpregnancyinthespraguedawleyrat
AT strynarmarkj cumulativematernalandneonataleffectsofcombinedexposuretoamixtureofperfluorooctanoicacidpfoaandperfluorooctanesulfonicacidpfosduringpregnancyinthespraguedawleyrat
AT fordjermaine cumulativematernalandneonataleffectsofcombinedexposuretoamixtureofperfluorooctanoicacidpfoaandperfluorooctanesulfonicacidpfosduringpregnancyinthespraguedawleyrat
AT graylearl cumulativematernalandneonataleffectsofcombinedexposuretoamixtureofperfluorooctanoicacidpfoaandperfluorooctanesulfonicacidpfosduringpregnancyinthespraguedawleyrat